Home/Filings/4/0000950170-24-016185
4//SEC Filing

Herzich Paul 4

Accession 0000950170-24-016185

CIK 0001707502other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 11:02 AM ET

Size

8.9 KB

Accession

0000950170-24-016185

Insider Transaction Report

Form 4
Period: 2024-02-13
Herzich Paul
Chief Technology Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2024-02-13+57,50057,500 total
    Exercise: $7.85Exp: 2034-02-13Common Stock (57,500 underlying)
  • Award

    Restricted Stock Units

    2024-02-13+28,75028,750 total
    Common Stock (28,750 underlying)
Holdings
  • Common Stock

    6,022
Footnotes (4)
  • [F1]Includes 1,752 shares of the issuer's common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 30, 2023.
  • [F2]This option was granted on February 13, 2024 (the "Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock (the "RSUs").
  • [F4]The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.

Documents

1 file

Issuer

Solid Biosciences Inc.

CIK 0001707502

Entity typeother

Related Parties

1
  • filerCIK 0001954991

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 11:02 AM ET
Size
8.9 KB